ピエゾ電気的触媒メカニズムに基づく超音波反応薬剤投与システム
Kaixi Cui1, Tianzheng Li2, Yifei Ma3
1Hongshen Honors School, Chongqing University, Chongqing 400044, China.
Journal of functional biomaterials
|August 27, 2025
まとめ
この研究では,局所的な薬物投与のための反応性酸素種 (ROS) を生成するために,バリウムチタナートナノ粒子を用いた超音波活性化ヒドロゲルシステムを提示しています. このピエゾカタリシスのアプローチは,腫瘍の微小環境内で薬物の放出を制御することを可能にします.
科学分野:
- バイオマテリアル科学
- ナノテクノロジー
- 薬物投与システム
背景:
- 超音波に反応するナノマテリアルは 腫瘍への非侵襲的な局所的な薬剤投与の可能性を秘めています
- 効果的な刺激反応システムの開発は 標的型がん治療に不可欠です
研究 の 目的:
- 超音波で薬剤を放出するピエゾカタリシス補助ヒドロゲルシステムを開発する.
- 活性酸素種 (ROS) 生成と薬物の制御された放出を統合し,治療効果を向上させる.
主な方法:
- バリウムチタナート (BTO) ナノ粒子を含む水素ゲルマトリックス製造.
- ROS (ヒドロキシルラジカル,シングレット酸素) の生成のためのBTOピエゾカタリシス活性化のための超音波照射.
- ROS運動,薬物放出プロファイル,ナノ粒子特性 (TEM,XRD,XPS),および細胞互換性 (3T3 線維質) の評価.
主要な成果:
- 超音波曝露は,BTOピエゾカタリシスによるROS生成を誘導し,ヒドロゲルの分解につながった.
- 封装された治療薬の制御された放出は,シミュレートされた酸化および音響条件下で達成されました.
- 特徴はBTOナノ粒子の品質と安定性を確認し,良好な細胞相容性を示した.
結論:
- 開発されたシステムは,ピエゾ触媒ROS生成と水素ゲル分解を合力的に組み合わせています.
- このアプローチは,高度な超音波媒介薬剤投与プラットフォームの実現可能な戦略を示しています.
- このシステムは腫瘍の微小環境における 局所的で非侵襲的な治療用途の有望性を示しています
さらに関連する動画
07:16Assembly and Operation of an Acoustofluidic Device for Enhanced Delivery of Molecular Compounds to Cells
Published on: January 21, 2021
3.1K
06:02Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
Published on: June 12, 2021
4.0K
関連する概念動画
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...